This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Life Sciences and Health Care

Shaping the evolution of an industry

The Life Sciences and Health Care industry group strives to support clients in addressing challenges that impact the industry. As the life sciences and health care industry continues to evolve, professionals from across Deloitte's global network engage with clients to develop innovative solutions to help them achieve their respective business missions and move closer to their vision for the future. Contact the LSHC group to learn more about Deloitte's global industry practice.

Transformation beyond reform: A changing life sciences & health care industry Transformation beyond reform: A changing life sciences & health care industry
In conjunction with the Financial Times/Deloitte 2013 Health Care & Life Sciences conference, explore what lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform.
   
Health care reform and life sciences: Threat, opportunity or both? Health care reform and life sciences: Threat, opportunity or both?
New survey shows enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts on the life sciences industry from health care reforms around the world.
   
Deloitte ranked #1 in life sciences Deloitte ranked #1 in life sciences
Deloitte has been ranked number one in Life Sciences consulting services by Kennedy Information based on revenue. Ranking covers the four subsectors: pharmaceutical, biotechnology, medical device, and drug distribution.
   
2013 Deloitte survey of U.S. physicians: Perspectives about health care reform 2013 Deloitte survey of U.S. physicians: Perspectives about health care reform
U.S. physicians are concerned future of medical profession may be in jeopardy and performance of the U.S. health care system is suboptimal, but the Affordable Care Act will address this.
   
2013 Global life sciences sector outlook 2013 Global life sciences sector outlook
New report examines the current state of the global life sciences industry, explores top issues, reviews activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2013 and beyond.

 

 

 

 

 

 

 

 

 

 

More Learn more

  • Deloitte ranked #1 in life sciences
    As ranked by Kennedy Information
  • Measuring the return from pharmaceutical innovation 2012
    Exploring the pharmaceutical industry's performance
  • Life Sciences: Accounting and Financial Reporting Update
    Specialized life sciences accounting and reporting considerations

Related links

  • Follow us on Twitter
    Get our latest health care Tweets.
  • Life Sciences & Health Care research
    The latest industry reports.
  • Complimentary subscriptions
    Latest offerings.
  • Monday Memos
    Subscribe to weekly series on U.S. health care reform.
  • Meet our people
    Leadership profiles.

More Analyst accolades

  • Kennedy ranks Deloitte #1 global healthcare consulting practice
    Breadth of capabilities and aggregate revenue cited.

Stay connected

  • Contact us
  • Submit RFP
  • Global blog
  • Global podcasts
  • Social media
  • RSS feed
Stay connected:
Get connected
Share your comments

More on Deloitte
Learn about our site


Recently blogged